Horacio G. Nastri,Christel Iffland,Olivier Leger,Qi An,Mark Cartwright,Sean D. McKenna,Vanita D. Sood,Gang Hao
申请号：
US15454939
公开号：
US20170253653A1
申请日:
2017.03.09
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present application relates to anti-PD-L1 antibodies or antigen binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, such as tumor immunity, for the treatment of and cancer.
